Sweet
Value
Lab
Methodology
Pricing
Contineum Therapeutics, Inc. Class A Common Stock
CTNM
Healthcare
Biotechnology
NASDAQ
Sign in to watch
$13.34
Market Cap: $498.06M
Valuation
Financials
Forecast
Compare
Historical Price
Solvency
Dividends
Transactions
People
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) Analyst Estimates